{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:11:15Z","timestamp":1761156675938,"version":"3.38.0"},"reference-count":21,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nephro.2018.10.007","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T04:50:33Z","timestamp":1556686233000},"page":"226-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["D\u00e9pistage de la maladie de Fabry\u00a0: r\u00e9sultats de la premi\u00e8re enqu\u00eate fran\u00e7aise sur les pratiques des n\u00e9phrologues"],"prefix":"10.1684","volume":"15","author":[{"given":"Clotilde","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Delion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Bertocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"issue":"Suppl 2","key":"10.1016\/j.nephro.2018.10.007_bib0110","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/01.ASN.0000015236.70757.C4","article-title":"Biochemical and molecular genetic basis of Fabry disease","volume":"13","author":"Pastores","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.nephro.2018.10.007_bib0115","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1097\/01.ASN.0000015239.57436.18","article-title":"Anderson-Fabry disease: extrarenal, neurologic manifestations","volume":"13","author":"Kolodny","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2018.10.007_bib0120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40620-015-0193-1","article-title":"Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease","volume":"28","author":"Gaggl","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2018.10.007_bib0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2018.10.007_bib0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review","volume":"47","author":"Linthorst","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.nephro.2018.10.007_bib0135","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2018.10.007_bib0140","first-page":"763","article-title":"[Fabry disease: clinical aspects and therapeutic perspectives]","volume":"130","author":"Barbey","year":"2000","journal-title":"Schweiz Med Wochenschr"},{"year":"2010","series-title":"Maladie de Fabry. Protocole national de diagnostic et de soins. Guide \u2013 Affection de longue dur\u00e9e","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","key":"10.1016\/j.nephro.2018.10.007_bib0145"},{"key":"10.1016\/j.nephro.2018.10.007_bib0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfs526","article-title":"Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice","volume":"28","author":"Terryn","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2018.10.007_bib0155","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the Pharmacologic Chaperone Migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2018.10.007_bib0160","unstructured":"Agence de la Biom\u00e9decine. Rapport annuel 2015. www.agencebiomedecine.fr\/IMG\/pdf\/rapport_rein_2015.pdf."},{"year":"2016","series-title":"Atlas de la d\u00e9mographie m\u00e9dicale en France","author":"Bouet","key":"10.1016\/j.nephro.2018.10.007_bib0165"},{"key":"10.1016\/j.nephro.2018.10.007_bib0170","unstructured":"Centre de r\u00e9f\u00e9rence des maladies endocriniennes, de la croissance et du d\u00e9veloppement. R\u00e9seau des centres d\u2019endocrinologie. http:\/\/crmerc.aphp.fr\/base-de-donn\u00e9es-cemara\/."},{"key":"10.1016\/j.nephro.2018.10.007_bib0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/heartjnl-2014-306782","article-title":"Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease","volume":"101","author":"Patel","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.nephro.2018.10.007_bib0180","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/heartjnl-2011-300364","article-title":"Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey","volume":"97","author":"Elliott","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.nephro.2018.10.007_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/joim.12089","article-title":"Fabry disease: is there a role for enzyme replacement therapy?","volume":"274","author":"Mehta","year":"2013","journal-title":"J Intern Med"},{"year":"1993","series-title":"Fabry Disease","author":"Adam","key":"10.1016\/j.nephro.2018.10.007_bib0190"},{"key":"10.1016\/j.nephro.2018.10.007_bib0195","doi-asserted-by":"crossref","first-page":"e0173358","DOI":"10.1371\/journal.pone.0173358","article-title":"Enzyme replacement therapy for Anderson-Fabry disease: a complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies","volume":"12","author":"Dib El","year":"2017","journal-title":"Plos One"},{"key":"10.1016\/j.nephro.2018.10.007_bib0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nephro.2015.07.471","article-title":"[Mineral-based alkaline waters\u2019 prescription in France: Patients are the key point for both nephrologists and urologists]","volume":"12","author":"Citarda","year":"2016","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2018.10.007_bib0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.nephro.2016.11.002","article-title":"[French teaching in nephrology: what is the residents\u2019 feeling? Results from the first national survey]","volume":"13","author":"Brasme","year":"2017","journal-title":"Nephrol Ther"},{"year":"2017","series-title":"Atlas de la d\u00e9mographie m\u00e9dicale en France. Profils compar\u00e9s\u00a0: 2007\/2017\u00a0\u2013\u00a0Les territoires au c\u0153ur de la r\u00e9flexion. Situation au 1er\u00a0janvier","author":"Bouet","key":"10.1016\/j.nephro.2018.10.007_bib0105"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725519300501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725519300501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2018.10.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:34:33Z","timestamp":1741185273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725519300501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1769725519300501"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2018.10.007","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9pistage de la maladie de Fabry\u00a0: r\u00e9sultats de la premi\u00e8re enqu\u00eate fran\u00e7aise sur les pratiques des n\u00e9phrologues","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}